It is known that BP can be triggered by systemic medications being used by the patient [1,2,5,6,7]. Several pharmacological classes are involved, but one of the most commonly used in clinical practice is DPP-4 inhibitors, prescribed for the management of type 2 Diabetes Mellitus [5,6,7]. Here, DPP4 is linked to type 2 diabetes mellitus.